Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02093468 · ClinicalTrials.gov registry record · Phase 2
Evaluation of MST-188 in Acute Lower Limb Ischemia
A Phase 2 study, sponsored by Mast Therapeutics.
- Terminated
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT02093468: Clinical Trial Phase 2 study, sponsored by Mast Therapeutics.
NCT02093468 is a Phase 2 study that was terminated before completion, run by Mast Therapeutics. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02093468, a Phase 2 study, was terminated before completion, sponsored by Mast Therapeutics.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected blood vessel.
Interventions
- DRUG Saline
- DRUG MST-188
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2014-06 |
| Phase | Phase 2 |
Why NCT02093468 stopped before completion
NCT02093468 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT02093468 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02093468 about?
NCT02093468 is a clinical study titled "Evaluation of MST-188 in Acute Lower Limb Ischemia". The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected b...
What is the current status of trial NCT02093468?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2014-06.
What interventions are being tested in trial NCT02093468?
The interventions under investigation include: Saline (DRUG), MST-188 (DRUG).
Who is sponsoring clinical trial NCT02093468?
This trial is sponsored by Mast Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02093468's enrollment target sits among peer trials
4 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia